Sign In
Buy HUM
$327.54
+6.66 (+2.08%)
At Close: Jun 03, 2026
5 HMO Stocks in Focus Amid an Aging U.S. Population, Tech Innovation
11:25am, Wednesday, 03'rd Jun 2026
Aging demographics, sound Medicare premiums, digital healthcare adoption and increased M&A activity are likely to drive the performance of the Zacks Medical-HMO industry players. UNH, CI, HUM, CNC and
Humana Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Humana Inc. - HUM
11:00pm, Friday, 29'th May 2026
Humana Investigation Continued: Kahn Swick and Foti, LLC Continues to Investigate the Officers and Directors of Humana Inc. - HUM
Humana Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Humana Inc. - HUM
10:00pm, Friday, 29'th May 2026
NEW ORLEANS, May 29, 2026 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq.
Humana (HUM) Up 30.6% Since Last Earnings Report: Can It Continue?
12:31pm, Friday, 29'th May 2026
Humana (HUM) reported earnings 30 days ago. What's next for the stock?
Humana completes $83 million Florida infrastructure investment to deepen coordinated patient care approach
08:00am, Wednesday, 27'th May 2026
ORLANDO, Fla.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM), one of the nation's leading health and well-being companies, today announced the start of full operations of its newest CenterWell Pharmacy® m
Congressional Joint Economic Committee Pegs Medicare Advantage Overpayments at $7 Billion Annually and Rising
01:30pm, Friday, 22'nd May 2026
According to Kiplinger, the Congressional Joint Economic Committee found Medicare Advantage is overpaying insurers by $212 per enrollee.
Humana Just Got a Massive Upgrade From Deutsche Bank: Price Target Nearly Doubles to $441
10:46am, Wednesday, 20'th May 2026
Deutsche Bank just delivered one of the most aggressive analyst upgrades of 2026 on Humana (NYSE:HUM | HUM Price Prediction), lifting the managed care giant to Buy from Hold while nearly doubling its
Pre-Market Stock Futures: Futures are trading higher on the heels of the third straight day of stock declines, and there is growing apprehension that yields will go even higher and that inflation may
Here's Why Investors Should Stay Neutral on Humana Stock for Now
12:16pm, Tuesday, 19'th May 2026
HUM's Medicare growth, CenterWell expansion and strong cash flow support gains, but rising costs and high leverage keep caution in focus.
Humana Just Ripped 48% in a Month. Is It Outperforming Other Healthcare Stocks Like UnitedHealth and Cigna?
02:48pm, Monday, 18'th May 2026
Shares of Humana (NYSE:HUM | HUM Price Prediction) are trading near $303 at midday Monday, slightly lower on the session after a flat open.
Humana: Perhaps The 'Buy The Dip' Thesis Was Right All Along (Rating Upgrade)
01:49pm, Monday, 18'th May 2026
Humana Inc. is upgraded to Buy as shares rebound from a >65% decline, supported by improved CMS rate decisions and activist investor involvement. Despite 2026 EPS guidance below Q1 levels, HUM targets
Humana Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Humana Inc. - HUM
05:32pm, Friday, 15'th May 2026
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its invest
Piper Sandler Just Hiked Humana Price Target to $254: Medicare Advantage Beat Powers the Bull Case
11:06am, Wednesday, 13'th May 2026
Humana (NYSE:HUM | HUM Price Prediction) stock received a price target raise to $254 from $182 from Piper Sandler, which maintained a Neutral rating.
Humana Invests More Than $1 Million to Advance Health Outcomes Across Louisiana
09:29am, Wednesday, 13'th May 2026
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana invests more than $1 million to advance health outcomes across Louisiana through grants that support statewide priorities.
Diamond Hill Small-Mid Cap Strategy Q1 2026 Portfolio Activity
12:27pm, Thursday, 07'th May 2026
We do not believe Humana's current share price reflects the company's earnings power, and as industry conditions normalize, we believe it can return to target margins over the long term. We initiated
